SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : CELSION CORP. (CLN was CELN) UP $.33 TO $.59 ON HUGE NEWS
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tech Master who wrote (464)5/3/1999 11:25:00 AM
From: Dave Gore  Read Replies (1) of 518
 
** For those not grasping the significance, CELN's BPH technology helps up to 50% of men over 50 years old WORLDWIDE, and gives many of them important relief without going under the knife for prostate surgery.

The significance of this is almost overwhelming and of world importance.

Can you imagine the relief to millions in knowing that an outpatient procedure exists?

This is a $10 BILLION dollar worldwide market right now and only 23% of all men with prostate problems are seeking help, because the only consequence of doing so is embarrassment and major surgery under the knife.

So a $40B market is more realistic, since less that 1/4 of all men right now are seeking help that they probably need.

Also remember that only PHASE I and PHASE II is required for medical equipment technology. There is no Phase III required as there is in drug approval.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News